Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-28392375

ABSTRACT

Increasing prevalence of antibiotic resistance has led research to focus on discovering new antimicrobial agents derived from the marine biome. Although ample studies have investigated sponges for their bioactive metabolites with promising prospects in drug discovery, the potentiating effects of sponge extracts on antibiotics still remains to be expounded. The present study aimed to investigate the antibacterial capacity of seven tropical sponges collected from Mauritian waters and their modulatory effect in association with three conventional antibiotics namely chloramphenicol, ampicillin and tetracycline. Disc diffusion assay was used to determine the inhibition zone diameter (IZD) of the sponge total crude extracts (CE), hexane (HF), ethyl acetate (EAF) and aqueous (AF) fractions against nine standard bacterial isolates whereas broth microdilution method was used to determine their minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs) and antibiotic potentiating activity of the most active sponge extract. MIC values of the sponge extracts ranged from 0.039 to 1.25mg/mL. Extracts from Neopetrosia exigua rich in beta-sitosterol and cholesterol displayed the widest activity spectrum against the 9 tested bacterial isolates whilst the best antibacterial profile was observed by its EAF particularly against Staphylococcus aureus and Bacillus cereus with MIC and MBC values of 0.039mg/mL and 0.078mg/mL, respectively. The greatest antibiotic potentiating effect was obtained with the EAF of N. exigua (MIC/2) and ampicillin combination against S. aureus. These findings suggest that the antibacterial properties of the tested marine sponge extracts may provide an alternative and complementary strategy to manage bacterial infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Aquatic Organisms/chemistry , Biological Products/pharmacology , Drug Agonism , Drug Discovery , Porifera/chemistry , Acetates/chemistry , Ampicillin/agonists , Ampicillin/pharmacology , Animals , Anti-Bacterial Agents/analysis , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Aquatic Organisms/growth & development , Biological Products/chemistry , Biological Products/isolation & purification , Chloramphenicol/agonists , Chloramphenicol/pharmacology , Disk Diffusion Antimicrobial Tests , Drug Resistance, Bacterial/drug effects , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/growth & development , Gram-Positive Bacteria/drug effects , Gram-Positive Bacteria/growth & development , Indian Ocean , Mauritius , Microbial Sensitivity Tests , Porifera/growth & development , Sitosterols/analysis , Sitosterols/isolation & purification , Sitosterols/pharmacology , Solvents/chemistry , Tetracycline/agonists , Tetracycline/pharmacology
2.
Foodborne Pathog Dis ; 12(6): 545-50, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26067230

ABSTRACT

Morin, a plant-derived flavonol, is known to be an effective inhibitor of Gram-positive bacteria. In this study, we explored the combined effect of morin with ß-lactam antibiotics against methicillin-resistant Staphylococcus aureus (MRSA), a multidrug-resistant pathogen. The anti-MRSA activity of morin was investigated by the broth microdilution method, checkerboard dilution test, and time-kill curve assay. The expression of the resistant protein, penicillin-binding protein (PBP2a) encoded by mecA, was analyzed by the Western blotting method in the presence of morin and oxacillin. An increased susceptibility of MRSA toward oxacillin was observed in the presence of morin. The protein level of PBP2a was reduced when MRSA (ATCC 33591) was treated with the combination of morin and oxacillin, indicating that the combination of morin and oxacillin potentiates the killing effect against MRSA. The present study indicates that the killing effect by the combinative treatment of morin and ß-lactam antibiotic is dependent on the PBP2a-mediated resistance mechanism.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/antagonists & inhibitors , Drug Resistance, Multiple, Bacterial/drug effects , Flavonoids/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Penicillin-Binding Proteins/antagonists & inhibitors , beta-Lactams/agonists , Ampicillin/agonists , Ampicillin/pharmacology , Anti-Bacterial Agents/chemistry , Bacterial Proteins/metabolism , Cell Membrane/drug effects , Cell Membrane/ultrastructure , Cell Wall/drug effects , Cell Wall/ultrastructure , Colony Count, Microbial , Cytoplasm/drug effects , Cytoplasm/ultrastructure , Drug Synergism , Humans , Methicillin-Resistant Staphylococcus aureus/growth & development , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Methicillin-Resistant Staphylococcus aureus/metabolism , Microbial Sensitivity Tests , Microbial Viability/drug effects , Microscopy, Electron, Transmission , Oxacillin/agonists , Oxacillin/pharmacology , Penicillin-Binding Proteins/metabolism , Republic of Korea , Staphylococcal Infections/microbiology , beta-Lactams/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...